Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic Patients
Clinical trial NCT00781794 · WITHDRAWN
Trial details
- NCT number
- NCT00781794
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2009-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.